Effects of Polybrominated Diphenyl Ethers on Rat and Human 11β-Hydroxysteroid Dehydrogenase 1 and 2 Activities

Polybrominated diphenyl ethers (PBDEs) are a class of brominated flame retardants. PBDEs have been widely used in textiles, flexible polyurethane foams, electronic components, electrical components, and plastics. 11β-Hydroxysteroid dehydrogenases, isoform 1 (HSD11B1) and isoform 2 (HSD11B2), have been demonstrated to be the regulators of local glucocorticoid levels. In this study, the potencies of 4 different PBDEs (BDE-3, BDE-47, BDE-100, and BDE-153) with 1-6 bromine atoms attached in inhibition of rat and human HSD11B1 and HSD11B2 activities were compared to 4-bromobiphenyl (BBP), a structurally similar compound. All 4 PBDEs and BBP did not inhibit rat and human HSD11B1. BDE-3 and BDE-47 potently inhibited rat HSD11B2, and BDE-47 and BDE-153 potently inhibited human HSD11B2, with the half maximal inhibitory concentration values of 12.42, 5.95, 11.97, and 4.41 µmol/l, respectively. All PBDEs noncompetitively inhibited HSD11B2 when a steroid substrate was used. However, PBDEs exerted uncompetitive inhibition when the cofactor NAD+ was used. In conclusion, some PBDEs are selective inhibitors of HSD11B2, possibly causing excessive glucocorticoid action in local tissues.

[1]  Colleen M Makey,et al.  Polybrominated Diphenyl Ether Exposure and Thyroid Function Tests in North American Adults , 2015, Environmental health perspectives.

[2]  J. Cidlowski,et al.  Glucocorticoid signaling in the heart: A cardiomyocyte perspective , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  L. Fañanás,et al.  Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of early adversity in stress-related disorders causality: A critical review , 2015, Neuroscience & Biobehavioral Reviews.

[4]  A. Alzahrani,et al.  Apparent Mineralocorticoid Excess Caused by a Novel Mutation in 11-β Hydroxysteroid Dehydrogenase Type 2 Enzyme: Its Genetics and Response to Therapy. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  M. Hill,et al.  Steroid profiling in pregnancy: A focus on the human fetus , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Q. Lian,et al.  Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. , 2011, Toxicology.

[7]  D. Hardy,et al.  The (+)- and (−)-gossypols potently inhibit human and rat 11β-hydroxysteroid dehydrogenase type 2 , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  S. Ohno,et al.  Leydig cells from neonatal pig testis abundantly express 11β-hydroxysteroid dehydrogenase (11β-HSD) type 2 and effectively inactivate cortisol to cortisone , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  J. Seckl,et al.  Mechanisms of Disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[10]  D. Hardy,et al.  11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate. , 2005, Endocrinology.

[11]  Jeremy W Tomlinson,et al.  11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response , 2004 .

[12]  T. Mune,et al.  11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. , 2001, Pediatric research.

[13]  J. Boer,et al.  Do flame retardants threaten ocean life? , 1998, Nature.

[14]  R. Benediktsson,et al.  Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure , 1997 .

[15]  A. Brouwer,et al.  Binding of a 3,3', 4,4'-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice. , 1996, Toxicology.

[16]  R. Benediktsson,et al.  Placental 11β-hydroxysteroid dehydrogenase and the programming of hypertension , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  T. Mune,et al.  Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase , 1995, Nature Genetics.

[18]  J. Dowling,et al.  Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  T. Mune,et al.  Cloning of cDNA encoding an NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase in sheep kidney. , 1995, Endocrine research.

[20]  Z. Krozowski,et al.  Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme , 1994, Molecular and Cellular Endocrinology.

[21]  N. Kerkvliet,et al.  Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. , 1994, Toxicology.

[22]  C. Monder,et al.  Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex* , 1988 .

[23]  C. Edwards,et al.  Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.

[24]  J. Funder,et al.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. , 1988, Science.

[25]  D. Housman,et al.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.

[26]  C. Monder,et al.  Extraction of 11 beta-hydroxysteroid dehydrogenase from rat liver microsomes by detergents. , 1985, Journal of steroid biochemistry.

[27]  E. Kajantie,et al.  Placental 11β-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants , 2003 .

[28]  T. Mune,et al.  11β-Hydroxysteroid Dehydrogenase and Its Role in the Syndrome of Apparent Mineralocorticoid Excess , 1997, Pediatric Research.

[29]  R. Benediktsson,et al.  Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. , 1995, Journal of Steroid Biochemistry and Molecular Biology.

[30]  C. Monder,et al.  Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex. , 1988, Endocrinology.